Literature DB >> 11697795

Differential expression of neuroleukin in osseous tissues and its involvement in mineralization during osteoblast differentiation.

J Zhi1, D W Sommerfeldt, C T Rubin, M Hadjiargyrou.   

Abstract

Osteoblast differentiation is a multistep process that involves critical spatial and temporal regulation of cellular processes marked by the presence of a large number of differentially expressed molecules. To identify key functional molecules, we used differential messenger RNA (mRNA) display and compared RNA populations isolated from the defined transition phases (proliferation, matrix formation, and mineralization) of the MC3T3-E1 osteoblast-like cell line. Using this approach, a complementary DNA (cDNA) fragment was isolated and identified as neuroleukin (NLK), a multifunctional cytokine also known as autocrine motility factor (AMF), phosphoglucose isomerase (PGI; phosphohexose isomerase [PHI]), and maturation factor (MF). Northern analysis showed NLK temporal expression during MC3T3-E1 cell differentiation with a 3.5-fold increase during matrix formation and mineralization. Immunocytochemical studies revealed the presence of NLK in MC3T3-E1 cells as well as in the surrounding matrix, consistent with a secreted molecule. In contrast, the NLK receptor protein was detected primarily on the cell membrane. In subsequent studies, a high level of NLK expression was identified in osteoblasts and superficial articular chondrocytes in bone of 1-, 4-, and 8-month-old normal mice, as well as in fibroblasts, proliferating chondrocytes, and osteoblasts within a fracture callus. However, NLK was not evident in hypertrophic chondrocytes or osteocytes. In addition, treatment of MC3T3 cells with 6-phosphogluconic acid (6PGA; a NLK inhibitor) resulted in diminishing alkaline phosphatase (ALP) activity and mineralization in MC3T3-E1 cells, especially during the matrix formation stage of differentiating cells. Taken together, these data show specific expression of NLK in discrete populations of bone and cartilage cells and suggest a possible role for this secreted protein in bone development and regeneration.

Entities:  

Keywords:  NASA Discipline Musculoskeletal; Non-NASA Center

Mesh:

Substances:

Year:  2001        PMID: 11697795     DOI: 10.1359/jbmr.2001.16.11.1994

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  8 in total

1.  Silencing of autocrine motility factor induces mesenchymal-to-epithelial transition and suppression of osteosarcoma pulmonary metastasis.

Authors:  Yasufumi Niinaka; Kiyoshi Harada; Masahiro Fujimuro; Masamitsu Oda; Arayo Haga; Misa Hosoki; Narikazu Uzawa; Naoya Arai; Satoshi Yamaguchi; Masashi Yamashiro; Avraham Raz
Journal:  Cancer Res       Date:  2010-10-26       Impact factor: 12.701

2.  The lipogenic gene spot 14 is activated in bone by disuse yet remains unaffected by a mechanical signal anabolic to the skeleton.

Authors:  Jizu Zhi; Gang Xu; Clinton T Rubin; Michael Hadjiargyrou
Journal:  Calcif Tissue Int       Date:  2008-01-25       Impact factor: 4.333

3.  Prognostic significance of 18F-FDG uptake in primary osteosarcoma after but not before chemotherapy: a possible association with autocrine motility factor/phosphoglucose isomerase expression.

Authors:  Junko Sato; Takashi Yanagawa; Yoh Dobashi; Takehiko Yamaji; Kenji Takagishi; Hideomi Watanabe
Journal:  Clin Exp Metastasis       Date:  2008-02-27       Impact factor: 5.150

4.  Core-binding factor beta is required for osteoblast differentiation during fibula fracture healing.

Authors:  Tuanmao Guo; Yanli Xing; Zhongning Chen; Xianhong Wang; Haiyun Zhu; Lan Yang; Yong Yan
Journal:  J Orthop Surg Res       Date:  2021-05-14       Impact factor: 2.359

5.  Dihydrotestosterone, a robust promoter of osteoblastic proliferation and differentiation: understanding of time-mannered and dose-dependent control of bone forming cells.

Authors:  Hnin Ei Thu; Isa Naina Mohamed; Zahid Hussain; Ahmad Nazrun Shuid
Journal:  Iran J Basic Med Sci       Date:  2017-08       Impact factor: 2.699

6.  Amplification of autocrine motility factor and its receptor in multiple myeloma and other musculoskeletal tumors.

Authors:  Kosei Nakajima; Avraham Raz
Journal:  J Bone Oncol       Date:  2020-07-15       Impact factor: 4.072

7.  Neuroleukin/Autocrine Motility Factor Receptor Pathway Promotes Proliferation of Articular Chondrocytes through Activation of AKT and Smad2/3.

Authors:  Kang Tian; Weiliang Zhong; Xifu Zheng; Jinrui Zhang; Pixu Liu; Weiguo Zhang; Han Liu
Journal:  Sci Rep       Date:  2015-10-13       Impact factor: 4.379

8.  Microfluidics‑based optimization of neuroleukin‑mediated regulation of articular chondrocyte proliferation.

Authors:  Kang Tian; Weiliang Zhong; Yingqiu Zhang; Baosheng Yin; Weiguo Zhang; Han Liu
Journal:  Mol Med Rep       Date:  2015-11-10       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.